MEtformin vs Tolvaptan for tReatment
Of autosomal dominant POLycystic kidney dISease
Metformin versus Tolvaptan in adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD): a phase 3a, independent, multi-centre, 2 parallel arms randomized controlled trial